Nigella Sativa Oil

Phase 2Small molecule

UUniversity of Health Sciences Lahore

Nigella Sativa Oil is one of 123 small molecule programs targeting Allergy. It is currently in Phase 2.

Indications

Total Trials

Active Trials

122

Competitors

Pipeline

Status by Indication[3][1]

Indication

AllergyActive, not recruiting

PneumoniaActive, not recruiting

Oxidative StressActive, not recruiting

Chronic PeriodontitisActive, not recruiting

OsteoarthritisActive, not recruiting

AllergyPreclinical

Active, not recruiting

PneumoniaPreclinical

Active, not recruiting

Oxidative StressPhase 2/Phase 3

Active, not recruiting

Chronic PeriodontitisPhase 2

Active, not recruiting

OsteoarthritisPreclinical

Active, not recruiting

Competition

Competitive Landscape

778 competitors in Osteoarthritis

#DrugCompanyPhaseTrials

Nigella Sativa Oil

UUniversity of Health Sciences Lahore

Phase 2

1 2

Enbrel

IImmunex

Preclinical

2 3

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

1 4

Naproxen Sodium

Bayer

Preclinical

1 5

Botox

AbbVie

Preclinical

1 6

SGLT2 Inhibitor

Eli Lilly

Preclinical

1 7

Western Medicine

PPeking Union Medical College Hospital

Preclinical

1 8

Acetyl-L-Carnitine

Mario Negri Institute for Pharmacological Research

Preclinical

1 9

Duloxetine HCL

Eli Lilly

Preclinical

1 10

Phenol

NNorthwestern University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Chronic Periodontitis1 trial

Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis

Unknown status·UUniversity of Health Sciences Lahore·Phase 2·NCT03270280·25 enrolled

Pneumonia1 trial

Nigella Sativa as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia

Unknown status·RRehab Zaki Elmeazawy·N/A·NCT05952102·104 enrolled

Osteoarthritis1 trial

Effects of Nigella Sativa Oil on Pain Intensity and Physical Functions in Patients With Knee Osteoarthritis

Completed·SSultan ÇEÇEN·N/A·NCT05541185·75 enrolled

Allergy1 trial

The Efficacy of Nigella Sativa in Children With House Dust Mite-Induced Respiratory Allergy Receiving Immunotherapy

Unknown status·UUniversitas Airlangga·N/A·NCT05450289·40 enrolled

Oxidative Stress1 trial

Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia

Completed·—·Phase 2/3·NCT04292314·350 enrolled

1 more indication

Alveolar Osteitis1 trial

A Comparative Single Blind Clinical Study on the Effect of Alvogyl, Eugenol, and Nigella Sativa (Black Seed Oil) for Alveolar Osteitis.

Not yet recruiting·HHITEC-Institute of Medical Sciences·Phase 2·NCT06823544·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Nigella Sativa Oil. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Nigella Sativa Oil compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Nigella Sativa Oil. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Health Sciences Lahore company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: UUniversity of Health Sciences Lahore

Nigella Sativa Oil

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Chronic Periodontitis1 trial

Pneumonia1 trial

Osteoarthritis1 trial

Allergy1 trial

Oxidative Stress1 trial

Alveolar Osteitis1 trial

References

Drug Info

Quick Facts

Related News